{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T06:24:01Z","timestamp":1787639041911,"version":"build-2736575974"},"reference-count":55,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To examine the association between glucose-lipid metabolism and psychotic symptoms in first-episode drug-na\u00efve (FEDN) major depressive disorder (MDD) patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A single-center cross-sectional study enrolled 1718 FEDN MDD patients (171 with, 1547 without psychotic symptoms). Fasting blood glucose, lipid profiles, body mass index, and HAMD, HAMA, PANSS scores were collected. Principal component analysis (PCA) reduced collinearity, serial association analysis explored association patterns, K-means clustering stratified metabolic risk, and multivariate logistic regression confirmed independent associations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Two metabolic components were extracted by PCA. The cholesterol-glucose-related first component (PC1) was most closely linked to psychotic symptoms. Cross-sectional path analysis showed that the statistical covariance between PC1 and psychotic symptoms was predominantly accounted for by the severity gradients of depressive and anxiety symptoms, with total indirect association 0.0440 (95% CI: 0.0361 - 0.0533) and no significant direct association. Participants were classified into three metabolic risk subgroups by PC1 scores. Prevalence of psychotic symptoms increased progressively across the low, medium, and high risk groups (0.61%, 3.44%, and 32.23%, respectively). Multivariate logistic regression validated metabolic risk as an independent predictor of psychotic symptoms, with adjusted ORs 0.076 (medium-risk) and 0.013 (low-risk) (all P &amp;lt; 0.001). Receiver operating characteristic analysis also showed its discriminative ability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Cholesterol-glucose metabolic alterations are associated with psychotic symptoms via sequential depressive and anxiety symptoms in FEDN MDD patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpsyt.2026.1916151","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T05:36:17Z","timestamp":1787636177000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Metabolic risk stratification and psychotic symptoms in first-episode drug-na\u00efve major depressive disorder: a principal component-based cross-sectional study"],"prefix":"10.3389","volume":"17","author":[{"given":"Miao","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Psychiatry, The Affiliated Brain Hospital of Nanjing Medical University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofang","family":"Shang","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, The Affiliated Brain Hospital of Nanjing Medical University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-E","family":"Lang","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, First Hospital of Shanxi Medical University","place":["Taiyuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjun","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Nanjing Meishan Hospital","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Hefei Fourth People\u2019s Hospital, Anhui Mental Health Center, Affiliated Psychological Hospital of Anhui Medical University","place":["Hefei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/s2215-0366(24)00317-1","article-title":"Service coverage for major depressive disorder: estimated rates of minimally adequate treatment for 204 countries and territories in 2021","volume":"11","author":"Santomauro","year":"2024","journal-title":"Lancet Psychiatry"},{"key":"B2","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/acps.13414","article-title":"Clinical and societal burden of incident major depressive disorder: a population\u2010wide cohort study in Stockholm","volume":"146","author":"Lundberg","year":"2022","journal-title":"Acta Psychiatr Scand"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/acps.70089","article-title":"Psychotic symptoms in unipolar and bipolar depression and their impact on disease prognosis: a systematic review","volume":"154","author":"Andreu","year":"2026","journal-title":"Acta Psychiatr Scand"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.o1557","article-title":"Management of depression in adults: summary of updated NICE guidance","volume":"378","author":"Kendrick","year":"2022","journal-title":"BMJ"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/s2215-0366(24)00030-0","article-title":"Pharmacological treatment of psychotic depression","volume":"11","author":"Flint","year":"2024","journal-title":"Lancet Psychiatry"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1159\/000511348","article-title":"Psychotic depression: diagnosis, differential diagnosis, and treatment","volume":"90","author":"Dubovsky","year":"2021","journal-title":"Psychother Psychosom"},{"key":"B7","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s13643-026-03121-0","article-title":"Understanding heterogeneity in prevalence meta-analyses: from structural incompatibility to statistical variation","volume":"15","author":"Bigna","year":"2026","journal-title":"Systematic Rev"},{"key":"B8","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13034-026-01078-5","article-title":"Abnormal connectivity in the fronto-striatal network in adolescent depression with psychotic symptoms","volume":"20","author":"Huang","year":"2026","journal-title":"Child Adolesc Psychiatry Ment Health"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2026.121436","article-title":"Plasma neurotransmitter-related metabolite alterations in adolescent major depressive disorder with and without psychotic features","volume":"405","author":"Luo","year":"2026","journal-title":"J Affect Disord"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2025.116494","article-title":"Unraveling the prevalence and key influencers of metabolic syndrome in drug-na\u00efve, first-episode major depressive disorder patients with psychotic symptoms: a decision tree modeling approach","volume":"348","author":"Wang","year":"2025","journal-title":"Psychiatry Res"},{"key":"B11","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/s41398-021-01759-z","article-title":"The association between depression and metabolic syndrome and its components: a bidirectional two-sample Mendelian randomization study","volume":"11","author":"Zhang","year":"2021","journal-title":"Transl Psychiatry"},{"key":"B12","doi-asserted-by":"publisher","first-page":"6280","DOI":"10.1038\/s41467-023-41963-7","article-title":"Metabolic phenotyping of BMI to characterize cardiometabolic risk: evidence from large population-based cohorts","volume":"14","author":"Beyene","year":"2023","journal-title":"Nat Commun"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2021-067516","article-title":"Anthropometric and adiposity indicators and risk of type 2 diabetes: systematic review and dose-response meta-analysis of cohort studies","volume":"376","author":"Jayedi","year":"2022","journal-title":"BMJ"},{"key":"B14","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jad.2006.07.020","article-title":"Assessing depressive symptoms in persons who die of suicide in mainland China","volume":"98","author":"Phillips","year":"2007","journal-title":"J Affect Disord"},{"key":"B15","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B16","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1093\/occmed\/kqv054","article-title":"Hamilton rating scale for anxiety (HAM-A)","volume":"65","author":"Thompson","year":"2015","journal-title":"Occup Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr Bull"},{"key":"B18","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1002\/da.23026","article-title":"Psychotic symptoms in first\u2010episode and drug na\u00efve patients with major depressive disorder: prevalence and related clinical factors","volume":"37","author":"Shen","year":"2020","journal-title":"Depress Anxiety"},{"key":"B19","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1186\/s12888-025-07186-4","article-title":"Prevalence and related factors of comorbid suicide attempts and psychotic symptoms in first-episode drug-na\u00efve patients with major depressive disorder","volume":"25","author":"Liu","year":"2025","journal-title":"BMC Psychiatry"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/bmsp.12336","article-title":"When and how to use set\u2010exploratory structural equation modelling to test structural models: a tutorial using the R package lavaan","volume":"77","author":"Marsh","year":"2024","journal-title":"Br J Math Stat Psychol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0125935","article-title":"Evidence in obese children: contribution of hyperlipidemia, obesity-inflammation, and insulin sensitivity","volume":"10","author":"Peterson","year":"2015","journal-title":"PloS One"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23158493","article-title":"Tryptophan metabolism in depression: a narrative review with a focus on serotonin and kynurenine pathways","volume":"23","author":"Correia","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1625087","article-title":"Lipid metabolic dysregulation-induced neuroinflammation in the pathophysiology of major depressive disorder","volume":"16","author":"Ge","year":"2025","journal-title":"Front Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s12944-024-02204-y","article-title":"Association between neutrophil to high-density lipoprotein cholesterol ratio (NHR) and depression symptoms among the United States adults: a cross-sectional study","volume":"23","author":"Qing","year":"2024","journal-title":"Lipids Health Dis"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s00406-025-01966-5","article-title":"Cholesterol metabolism and its implications in psychotic disorders: a comparative study of individuals at ultra high risk and control groups","volume":"276","author":"Moreno","year":"2025","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1111\/acps.13278","article-title":"Elevated lipids are associated with reduced regional brain structure in youth with bipolar disorder","volume":"143","author":"Kennedy","year":"2021","journal-title":"Acta Psychiatr Scand"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbab122","article-title":"Neural substrates of psychotic depression: findings from the global ECT-MRI research collaboration","volume":"48","author":"Takamiya","year":"2022","journal-title":"Schizophr Bull"},{"key":"B28","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.devcel.2025.08.011","article-title":"Environmental and genetic risk factors of depression converge on neuronal dysfunction driven by changes in cholesterol homeostasis","volume":"61","author":"Oberst","year":"2026","journal-title":"Dev Cell"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2025.1537644","article-title":"Fasting blood glucose mediated the association between a body shape index and depression: a cross sectional study from NHANES 2017\u20132023","volume":"12","author":"Chen","year":"2025","journal-title":"Front Nutr"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e2842","DOI":"10.1002\/dmrr.2842","article-title":"HPA axis dysregulation, NR3C1 polymorphisms and glucocorticoid receptor isoforms imbalance in metabolic syndrome","volume":"33","author":"Martins","year":"2016","journal-title":"Diabetes Metab Res Rev"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s0006-3223(03)00473-6","article-title":"Association of depression with medical illness: does cortisol play a role","volume":"55","author":"Brown","year":"2004","journal-title":"Biol Psychiatry"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a041355","article-title":"The astrocyte: metabolic hub of the brain","volume":"16","author":"Barros","year":"2024","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.476","article-title":"Cholesterol metabolism: physiological regulation and diseases","volume":"5","author":"Guo","year":"2024","journal-title":"MedComm"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-022-01494-x","article-title":"Schizophrenia: a disorder of broken brain bioenergetics","volume":"27","author":"Henkel","year":"2022","journal-title":"Mol Psychiatry"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.tics.2024.11.010","article-title":"The metabolic costs of cognition","volume":"29","author":"Jamadar","year":"2025","journal-title":"Trends Cognit Sci"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-025-02975-5","article-title":"Genetic and neural mechanisms shared by schizophrenia and depression","volume":"30","author":"Xie","year":"2025","journal-title":"Mol Psychiatry"},{"key":"B37","doi-asserted-by":"publisher","first-page":"4985","DOI":"10.1038\/s41467-026-71542-5","article-title":"Astrocyte fatty acid metabolism as a driver of risk for major depressive disorder","volume":"17","author":"Fitzgerald","year":"2026","journal-title":"Nat Commun"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1002\/wps.21110","article-title":"Comorbidity between major depressive disorder and physical diseases: a comprehensive review of epidemiology, mechanisms and management","volume":"22","author":"Berk","year":"2023","journal-title":"World Psychiatry Off J World Psychiatr Assoc (WPA)"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-026-03548-w","article-title":"A genome-wide investigation of depression among individuals with and without irritability","volume":"31","author":"St-Pierre","year":"2026","journal-title":"Mol Psychiatry"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1007\/s13679-023-00518-z","article-title":"Obesity and dyslipidemia: a review of current evidence","volume":"12","author":"Vekic","year":"2023","journal-title":"Curr Obes Rep"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2022.100457","article-title":"Effects of general and central adiposity on circulating lipoprotein, lipid, and metabolite levels in UK Biobank: a multivariable Mendelian randomization study","volume":"21","author":"Bell","year":"2022","journal-title":"Lancet Regional Health  Europe"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1017\/sjp.2021.46","article-title":"Mediation, moderation, and conditional process analysis: concepts, computations, and some common confusions","volume":"24","author":"Igartua","year":"2021","journal-title":"Spanish J Psychol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1146\/annurev-publhealth-032315-021402","article-title":"Mediation analysis: a practitioner's guide","volume":"37","author":"VanderWeele","year":"2016","journal-title":"Annu Rev Public Health"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2026.102653","article-title":"Lipid-lowering and glucose-lowering drug targets differentially modulate antipsychotic treatment efficacy in schizophrenia","volume":"7","author":"Zhu","year":"2026","journal-title":"Cell Rep Med"},{"key":"B45","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41398-025-03679-8","article-title":"Metabolomic biomarkers of psychotic conversion in ultra-high-risk subjects: a pilot study","volume":"15","author":"Avella","year":"2025","journal-title":"Transl Psychiatry"},{"key":"B46","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1017\/s1092852923002377","article-title":"Anxious distress in people with major depressive episodes: a cross-sectional analysis of clinical correlates","volume":"29","author":"Bartoli","year":"2023","journal-title":"CNS Spectrums"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2024.105625","article-title":"Antecedents of major depressive, bipolar, and psychotic disorders: a systematic review and meta-analysis of prospective studies","volume":"160","author":"Uher","year":"2024","journal-title":"Neurosci Biobehav Rev"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1017\/s0033291722002756","article-title":"Bidirectional relationships between cannabis use, anxiety and depressive symptoms in the mediation of the association with psychotic experience: further support for an affective pathway to psychosis","volume":"53","author":"Radhakrishnan","year":"2022","journal-title":"Psychol Med"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1002\/jts.22916","article-title":"Associations among psychosis, mood, anxiety, and posttraumatic stress symptoms: a network analysis","volume":"36","author":"Astill Wright","year":"2023","journal-title":"J Trauma Stress"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1186\/s12888-025-07513-9","article-title":"Similarities and differences of regional brain activity between first-episode drug-na\u00efve anxious and nonanxious MDD patients","volume":"25","author":"Liu","year":"2025","journal-title":"BMC Psychiatry"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1155\/2024\/4636291","article-title":"Resting\u2010state brain dynamics unique to anxiety in major depressive disorder","volume":"2024","author":"Du","year":"2024","journal-title":"Depress Anxiety"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2024.01.021","article-title":"Dysconnectivity of the brain functional network and abnormally expressed peripheral transcriptional profiles in patients with anxious depression","volume":"171","author":"Wei","year":"2024","journal-title":"J Psychiatr Res"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2025.120204","article-title":"Precision diagnostics for psychotic major depression: Construction and validation of a clinical indicator-based model","volume":"570","author":"Huang","year":"2025","journal-title":"Clin Chim Acta"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2024.07.012","article-title":"The transdiagnostic global impression - psychopathology scale (TGI-P): Initial development of a novel transdiagnostic tool for assessing, tracking, and visualising psychiatric symptom severity in everyday practice","volume":"88","author":"Correll","year":"2024","journal-title":"Eur Neuropsychopharmacol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.biopsych.2024.05.003","article-title":"Metabolic perspectives on depression: A step by step quest to illuminate the black box","volume":"96","author":"Mocking","year":"2024","journal-title":"Biol Psychiatry"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2026.1916151\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T05:36:19Z","timestamp":1787636179000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2026.1916151\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":55,"alternative-id":["10.3389\/fpsyt.2026.1916151"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2026.1916151","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]},"article-number":"1916151"}}